Metabolite | HMDB ID | Calrose | Dixiebelle | Neptune | Function | References |
---|---|---|---|---|---|---|
4-hydroxybenzoatea | 00500 | 1.18 | 1.87 | 1.04 | • Antimicrobial (broad spectrum bacteriostatic and fungistatic properties • Antioxidant (scavenges free radicals to reduce skin damage) | (Kosova et al. 2015) (Barreca et al. 2016) |
Abscisate | 35140 | 0.62 | 0.31 | 0.40 | • Anti-inflammatory (type II diabetes and obesity-related inflammation) | (Guri et al. 2007) |
Alpha-amyrina | 36657 | 0.06 | 0.08 | 0.12 | • Anti-inflammatory • Antimicrobial (broad spectrum bacteriostatic properties) | (Liliana Hernández Vázquez, 2012) |
Apigenin | 02124 | ND | 0.08 | 0.46 | • Cancer chemopreventive • Anti-inflammatory and anti-metastatic agent | (Balasubramanian et al. 2006) (Vargo et al. 2006) |
Astragalin | 37429 | ND | ND | 2.89 | • Anti-histaminergic (reduces IgE production) • Anti-parasitic (against Fasciolopsis buski) • Anti-inflammatory (reduces inflammation through nuclear factor NF-kB inhibition) • Neuroprotective (protects neurons from hydrogen peroxide-mediated cell death during neuroblastoma) | (Kotani et al. 2000) |
Benzoate | 01870 | 4.38 | 3.50 | 3.36 | • Antimicrobial (broad spectrum bacteriostatic and fungistatic properties) | (Nascimento et al. 2000) |
Caffeate | 01964 | ND | 0.20 | 1.23 | • Antioxidant • Cancer chemopreventive (functions as an antiproliferative chemotherapeutic agent) | (Olthof et al. 2001) (Rajendra Prasad et al. 2011) |
Chlorogenic acid | 03164 | ND | ND | 0.03 | • Antioxidant • Anti-diabetic (influences glucose metabolism by inhibiting alpha-glucosidase) • Anti-septic arthritis caused by Candida albicans. • Sleep-wake cycle modulator | (Olthof et al. 2001) (Upadhyay and Mohan Rao, 2013) |
Chrysoeriol | 30667 | 0.49 | 0.16 | 0.92 | • Antioxidant • Anti-inflammatory(Inhibits lipid peroxidation, inhibits production of superoxide anion by xanthine/xanthine oxidase system, inhibits the lipopolysaccharideinduction of the nitric oxide synthase (iNOS) gene.) | (Mishra et al. 2003) (Choi et al. 2005) |
Cinnamate | 00930 | 0.31 | 0.12 | 0.18 | • Antimicrobial (anti-mycobacterial agent that can be developed against tuberculosis) • Cancer chemopreventive (anti-proliferative activity against melanoma cells and lung carcinoma cells, inhibition of histone deacetylases in colon cancer cells) • Anti-obesogenic • Anti-hypertensive (inhibits serum lipase and angiotensin-converting enzyme) • Cardio-protective (In electrocardiography, it decreases the ST segment elevation induced by acute myocardial ischemia) • Antioxidant • Anti-inflammatory | (Y. L. Chen et al. 2011) (Zhu et al. 2016) (Mnafgui et al. 2015) (Song et al. 2013) |
Ergothioneinea | 03045 | ND | 0.79 | 0.99 | • Antioxidant | (Aruoma et al. 2012) |
Ferulate | 00954 | 6.22 | 10.28 | 19.69 | • Antioxidant | (Kanski et al. 2002 2002) |
Indolin-2-one | - | 1.19 | 0.30 | 3.80 | • Cancer chemopreventive (anti-proliferative and inhibits thioredoxin reductase (TrxR)) | (Kaminska et al. 2016) |
Luteolin | 05800 | ND | 0.04 | 1.67 | • Antioxidant (scavenges ROS) • Antimicrobial (broad spectrum gram positive bacteriostatic properties and yeast) | (Lin et al. 2008) (Singh et al. 2016) |
Piperidinea | 34301 | 0.76 | 0.69 | 0.91 | • Anti-hypertensive | |
Quinatea | 03072 | 8.86 | 1.65 | 7.27 | • Anti-inflammatory • Antioxidant | (Pero et al. 2009) |
Salicylate | 01895 | 6.67 | 0.48 | 2.12 | • Anti-diabetic (reduces blood glucose via activation of adenosine monophosphate-activated protein kinase)  • Anti-inflammatory | (Hawley et al. 2012) |
Sinapic acid | 32616 | 0.15 | 1.99 | 2.22 | • Anti-inflammatory • Anti-diabetic (increases expression of glucose transporter type 4) | (Yun et al. 2008) (Cherng et al. 2013) |
Sitostanol (Stigmastanol) | 00494 | ND | 0.10 | 0.06 | • Anti-hyperlipidemic | (Batta et al. 2006) |
Syringic acid | 02085 | 0.32 | 0.36 | 0.49 | • Antioxidant (prevents oxidative stress, inhibits the production of free radicals and reduces lipid peroxidation) • Antimicrobial (against Escherichia coli LY01 (g-), Cronobacter sakazakii (g-) and, Oenococcus oeni (g+)) • Anti-diabetic (enhancement of insulin action and C-peptide) | (Cikman et al. 2015) (Shi et al. 2016) (Muthukumaran et al. 2013) |
Tartaric acida | 00956 | 0.31 | 0.32 | 0.26 | • Antimicrobial (against E. coli, Bacillus subtilis and Streptococcus suis) | (Zhihong Gao, 2012) |
Vanillate | 00484 | 1.21 | 2.04 | 2.20 | • Antibacterial (against Cronobacter spp) • Anticoagulant (against snake venom) | (Yemis et al. 2011) (Dhananjaya et al. 2006) |
Vanillin | 12308 | 0.69 | 1.18 | 0.83 | • Antioxidant • Anti-inflammatory • Antibacterial (agains Cronobacter spp) • Treatment of sickle cell disease | (Makni et al. 2012; Makni et al. 2011) (Yemis et al. 2011) (Abdulmalik et al. 2011) |